According to Arrowhead Pharmaceuticals
's latest financial reports the company has $0.38 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-09-30 | $0.10 B | -74.08% |
2021-09-30 | $0.40 B | -11.47% |
2020-09-30 | $0.46 B | 89.23% |
2019-09-30 | $0.24 B | 156.23% |
2018-09-30 | $95.24 M | 17.77% |
2017-09-30 | $80.86 M | -14.9% |
2016-09-30 | $95.02 M | -13.32% |
2015-09-30 | $0.10 B | -33.96% |
2014-09-30 | $0.16 B | 544.98% |
2013-09-30 | $25.73 M | 192.15% |
2012-09-30 | $8.8 M | -29.89% |
2011-09-30 | $12.56 M | 55.53% |
2010-09-30 | $8.07 M | 66.29% |
2009-09-30 | $4.85 M | -60.51% |
2008-09-30 | $12.3 M | -53.5% |
2007-09-30 | $26.45 M | -16.29% |
2006-09-30 | $31.6 M | 12.81% |
2005-09-30 | $28.01 M | 149.57% |
2004-09-30 | $11.22 M | 690.7% |
2003-09-30 | $1.41 M | -191.56% |
2002-09-30 | $-1.56 M | 18.87% |
2001-09-30 | $-1.31 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $76.40 B | 19,903.14% | ๐บ๐ธ USA |
![]() Moderna
MRNA | $16.94 B | 4,337.09% | ๐บ๐ธ USA |
![]() Ligand Pharmaceuticals LGND | $0.66 B | 74.06% | ๐บ๐ธ USA |
![]() Alnylam Pharmaceuticals
ALNY | -$0.41 B | -206.84% | ๐บ๐ธ USA |
![]() Inovio Pharmaceuticals INO | $0.16 B | -55.66% | ๐บ๐ธ USA |